BMY vs DCO · P/E 17, rev $24.46B vs rev $433.5M
Bristol-Myers Squibb Company (BMY) versus Ducommun Incorporated (DCO) — a side-by-side from cached financials, not a winner call.
Bristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Chris Boerner.
Ducommun Incorporated (DCO) is a aerospace & defense company listed on US.
Latest reported BMY revenue for 2026-06-30 was $24.46B. Net income was $5.99B. BMY currently screens at market cap $95.36B and trailing P/E 17.5.
Latest reported DCO revenue for 2026-07-04 was $433.5M. Net income was $30.3M. DCO currently screens at market cap $2.30B.
BMY currently screens at market cap $95.36B and trailing P/E 17.5. DCO currently screens at market cap $2.30B.
Not investment advice. Open the BMY and DCO stock pages for the full models.
Not investment advice.